| 1.6 |
6.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.3 |
5.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 1.2 |
8.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.0 |
4.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.0 |
2.9 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.8 |
1.7 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.8 |
2.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
2.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.7 |
8.2 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.7 |
3.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.7 |
2.1 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.7 |
4.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.7 |
2.0 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.7 |
2.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.6 |
3.9 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.6 |
1.3 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.6 |
3.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
1.8 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.6 |
3.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.6 |
1.8 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.6 |
2.9 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 |
1.7 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.6 |
1.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.6 |
1.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
1.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.5 |
1.1 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 |
1.6 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.5 |
1.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.5 |
4.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.5 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.5 |
1.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 |
1.0 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.5 |
1.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.5 |
1.0 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.5 |
1.4 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.5 |
3.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 |
1.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 |
3.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.5 |
0.5 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.5 |
1.4 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
1.3 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
1.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.4 |
1.7 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.4 |
1.7 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 |
2.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.4 |
1.7 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.4 |
2.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
1.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.4 |
1.2 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.4 |
1.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.4 |
1.2 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 |
1.2 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.4 |
4.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.4 |
0.4 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.4 |
3.2 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.4 |
1.2 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.4 |
1.6 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.4 |
1.9 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.4 |
1.2 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
1.2 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.4 |
1.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 |
1.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.4 |
1.9 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.4 |
1.9 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.4 |
0.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.4 |
1.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.4 |
1.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
0.4 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 |
1.1 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.4 |
1.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 |
5.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.4 |
0.7 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.4 |
4.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 |
1.1 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
0.4 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.4 |
1.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.4 |
0.7 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.4 |
1.1 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 |
1.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.4 |
0.7 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.4 |
0.4 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.4 |
1.4 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.4 |
1.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
1.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.3 |
0.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 |
1.0 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.3 |
0.7 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 0.3 |
0.3 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 |
2.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
1.3 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 |
0.7 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 |
1.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
1.7 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
1.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
0.7 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.3 |
2.9 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.3 |
1.3 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
0.6 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.3 |
3.9 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.3 |
0.3 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
1.6 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 0.3 |
1.0 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.3 |
0.3 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
| 0.3 |
2.2 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.3 |
1.6 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.3 |
0.9 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
0.9 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
1.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
1.2 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.3 |
1.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
2.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
0.6 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.3 |
1.5 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.3 |
0.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.3 |
1.5 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.3 |
1.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
2.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
1.8 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.3 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 |
1.5 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.3 |
2.7 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.3 |
0.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
1.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.3 |
0.9 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.3 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.3 |
1.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
0.6 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.3 |
1.1 |
GO:0032899 |
regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
| 0.3 |
0.6 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.3 |
5.8 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.3 |
1.9 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.3 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.3 |
1.4 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 |
0.5 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.3 |
0.3 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.3 |
1.4 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.8 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.3 |
1.1 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.3 |
0.8 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
0.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
1.1 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.3 |
2.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.3 |
0.5 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.3 |
1.3 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 |
1.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
0.8 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 |
0.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
1.6 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
2.7 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.3 |
0.5 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.3 |
1.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
0.8 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.3 |
0.8 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 |
0.3 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 |
0.5 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.3 |
0.8 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 |
0.8 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.3 |
2.8 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.3 |
2.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
1.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
0.3 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.3 |
0.5 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.3 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
0.5 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
1.0 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 |
1.7 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
1.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.5 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 |
0.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
1.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.5 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.2 |
3.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 |
0.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.2 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.2 |
1.4 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 |
1.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
1.7 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
2.8 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.2 |
0.5 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.2 |
0.2 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
0.9 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
0.9 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
0.9 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.2 |
2.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
0.2 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.2 |
0.9 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
0.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
1.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
2.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.2 |
0.2 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.2 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.9 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 |
0.7 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
1.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
1.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.4 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 |
1.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
4.0 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
0.6 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.2 |
1.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.4 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
0.6 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.2 |
0.2 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 |
0.2 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.2 |
3.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
1.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
1.4 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 |
3.9 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
1.9 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
1.8 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
0.8 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
0.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.4 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.2 |
0.2 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 |
1.0 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
0.2 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 |
0.8 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
0.8 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
1.6 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 |
1.6 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
0.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.2 |
0.4 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 |
0.6 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
2.5 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
1.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
0.8 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.2 |
1.0 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.2 |
0.8 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.2 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.2 |
3.3 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.2 |
0.8 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.2 |
0.6 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
6.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
0.6 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
4.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
5.5 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
1.7 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.2 |
0.4 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
0.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.7 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.9 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.2 |
0.2 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.2 |
1.9 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
0.9 |
GO:0060264 |
regulation of respiratory burst involved in inflammatory response(GO:0060264) |
| 0.2 |
0.2 |
GO:0042637 |
catagen(GO:0042637) |
| 0.2 |
0.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.2 |
1.7 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
1.1 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.2 |
0.2 |
GO:0009757 |
carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.2 |
0.7 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
0.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.2 |
2.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
0.4 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
1.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
0.7 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
0.9 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.2 |
0.4 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
2.1 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
0.3 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 |
0.5 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
0.3 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.2 |
0.2 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
0.7 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.2 |
0.5 |
GO:0002363 |
alpha-beta T cell lineage commitment(GO:0002363) |
| 0.2 |
1.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
0.8 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
0.8 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
1.3 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.2 |
0.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.2 |
1.8 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
1.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
0.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.7 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 |
0.5 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.7 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
1.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
2.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.2 |
0.6 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 |
1.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 |
0.5 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.2 |
1.0 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 |
0.3 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.2 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.2 |
4.4 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.2 |
0.5 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
1.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
1.7 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.5 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
0.5 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
0.3 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.5 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.2 |
0.5 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.2 |
0.2 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.2 |
0.8 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
1.2 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
0.8 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.2 |
1.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
1.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
0.5 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.2 |
0.6 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
0.2 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.2 |
0.5 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
0.5 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
0.2 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 0.2 |
2.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.4 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
0.1 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.3 |
GO:0051305 |
meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
| 0.1 |
0.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.1 |
0.9 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.1 |
0.7 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.4 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
1.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
9.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.6 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte differentiation(GO:0003418) growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
1.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.3 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) negative regulation of alpha-beta T cell proliferation(GO:0046642) positive regulation of defense response to bacterium(GO:1900426) negative regulation of interferon-gamma secretion(GO:1902714) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 |
1.7 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
0.4 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 |
0.4 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.4 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.7 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.6 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.7 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
1.1 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.3 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 |
0.3 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.3 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
1.0 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.3 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.1 |
0.1 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 |
0.4 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
1.4 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.1 |
GO:0010608 |
posttranscriptional regulation of gene expression(GO:0010608) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.4 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.1 |
0.9 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.1 |
1.7 |
GO:0021684 |
cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
2.0 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.5 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.1 |
0.9 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.1 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.1 |
0.1 |
GO:0010934 |
macrophage cytokine production(GO:0010934) |
| 0.1 |
4.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.3 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.1 |
0.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
0.5 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.1 |
0.3 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.3 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.1 |
0.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
6.7 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
2.0 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.2 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.1 |
0.9 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.1 |
0.9 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.2 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.1 |
0.4 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.1 |
0.6 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.4 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.1 |
0.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.6 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.1 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.2 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 |
0.5 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 |
0.2 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.2 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.5 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.4 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.5 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.1 |
0.7 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.3 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.5 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
1.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
1.3 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.1 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
1.2 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
2.0 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.4 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
1.0 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.9 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
2.5 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.1 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
1.1 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
1.4 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.1 |
0.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
1.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
0.3 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.8 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.1 |
0.3 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.2 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.1 |
1.3 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.6 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
1.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.8 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
1.0 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
0.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
2.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.3 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.6 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
1.3 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
2.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
1.9 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
0.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
1.1 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.1 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.5 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.3 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.5 |
GO:0001821 |
histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.7 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.3 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
0.4 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.2 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.1 |
1.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.1 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
1.9 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.1 |
0.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.1 |
0.1 |
GO:1905063 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.1 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.3 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.1 |
GO:1903050 |
regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
| 0.1 |
0.4 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.7 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.3 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.1 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.1 |
0.1 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.1 |
0.1 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.1 |
1.1 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 |
0.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.9 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.3 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.2 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.1 |
0.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.1 |
1.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
1.0 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.4 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.1 |
0.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.1 |
0.3 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.1 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.6 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.3 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.1 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
0.7 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.6 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.3 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
0.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.1 |
0.2 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 |
0.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 |
0.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
1.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.9 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.1 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.1 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
2.9 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.2 |
GO:0032800 |
receptor biosynthetic process(GO:0032800) |
| 0.1 |
0.2 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
2.6 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.1 |
0.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.2 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.1 |
1.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.2 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.1 |
0.5 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.5 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.3 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
1.3 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
0.6 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.8 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 |
0.1 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.1 |
0.5 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.2 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.5 |
GO:0051307 |
resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
| 0.1 |
0.5 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.1 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.1 |
0.3 |
GO:0019740 |
nitrogen utilization(GO:0019740) |
| 0.1 |
0.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.1 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.4 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.9 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
1.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
1.1 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
0.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.5 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.6 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.6 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
1.1 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.6 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
0.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.6 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.4 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.3 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.1 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.2 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.4 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.1 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.1 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.3 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.3 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.2 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
1.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.6 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 |
0.5 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.1 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
0.3 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
0.5 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.3 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
1.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.1 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.1 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.4 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.3 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
0.6 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.2 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.1 |
0.4 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.3 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 |
0.3 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.1 |
0.2 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.2 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 |
0.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.1 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.1 |
0.4 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.2 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
0.4 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
0.7 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.6 |
GO:0051351 |
positive regulation of ligase activity(GO:0051351) |
| 0.1 |
0.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
1.2 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.1 |
3.7 |
GO:0007286 |
spermatid development(GO:0007286) |
| 0.1 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.1 |
0.2 |
GO:0060459 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.1 |
0.3 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.2 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.1 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.1 |
1.1 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.1 |
0.2 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
1.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.3 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.2 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.1 |
1.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.7 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.8 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.1 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 |
0.9 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.1 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 |
0.1 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.1 |
0.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.5 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.1 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.1 |
0.2 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 0.1 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.5 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.1 |
0.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.8 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.3 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.2 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
2.1 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.3 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.7 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.3 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.1 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.4 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.0 |
0.2 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
1.7 |
GO:0061640 |
cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.0 |
0.2 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.2 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) protection from natural killer cell mediated cytotoxicity(GO:0042270) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.0 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) cell cycle DNA replication(GO:0044786) |
| 0.0 |
0.1 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.3 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
1.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.4 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
0.0 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.1 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.2 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
1.1 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.0 |
0.3 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.0 |
0.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.9 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.6 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.4 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.2 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.0 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
1.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.5 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.0 |
0.9 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.6 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.7 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 |
0.1 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 |
0.7 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.3 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.3 |
GO:1902033 |
regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.0 |
0.1 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
0.1 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.0 |
0.1 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.5 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
1.2 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.6 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.4 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.0 |
0.2 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.0 |
0.0 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.0 |
0.1 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.3 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.0 |
0.3 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.7 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.0 |
0.5 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.2 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.1 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 |
0.4 |
GO:0032925 |
regulation of activin receptor signaling pathway(GO:0032925) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.0 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.0 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.0 |
0.1 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
1.0 |
GO:0050818 |
regulation of coagulation(GO:0050818) |
| 0.0 |
0.1 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) response to cycloheximide(GO:0046898) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
0.1 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.2 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.2 |
GO:0009074 |
aromatic amino acid family catabolic process(GO:0009074) |
| 0.0 |
0.0 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.0 |
0.4 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.0 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
0.9 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.1 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.0 |
0.1 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.1 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.2 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.1 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.0 |
0.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.7 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.2 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.5 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.1 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.0 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0070170 |
regulation of tooth mineralization(GO:0070170) |
| 0.0 |
0.1 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.0 |
0.5 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.3 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.9 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.7 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.1 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.2 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.1 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.0 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.0 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.0 |
0.4 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.0 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
0.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.3 |
GO:0034311 |
diol metabolic process(GO:0034311) |
| 0.0 |
0.2 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.5 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.8 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.6 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.2 |
GO:0036093 |
germ cell proliferation(GO:0036093) |
| 0.0 |
0.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.1 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.1 |
GO:0090049 |
regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.0 |
0.2 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.3 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.0 |
0.2 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.1 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.1 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
1.0 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 |
0.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.0 |
0.2 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.1 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.0 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.0 |
0.0 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.3 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.0 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.0 |
0.0 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.0 |
0.3 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.1 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.0 |
0.2 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.0 |
GO:0060088 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.0 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.0 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.0 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.3 |
GO:0071622 |
regulation of granulocyte chemotaxis(GO:0071622) |
| 0.0 |
0.1 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.1 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.1 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.0 |
0.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.3 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0002828 |
regulation of type 2 immune response(GO:0002828) |
| 0.0 |
0.0 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.4 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.0 |
0.0 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.0 |
0.8 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.1 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.0 |
0.0 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.0 |
0.0 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.1 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.0 |
0.5 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.0 |
0.0 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.1 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.0 |
0.7 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.0 |
0.0 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 |
0.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.2 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.0 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.0 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.3 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.0 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.0 |
0.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.0 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.0 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.1 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.0 |
0.0 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) response to folic acid(GO:0051593) |
| 0.0 |
0.0 |
GO:0000279 |
M phase(GO:0000279) cell cycle phase(GO:0022403) |
| 0.0 |
0.0 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 |
0.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.0 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.1 |
GO:1902369 |
negative regulation of RNA catabolic process(GO:1902369) |
| 0.0 |
0.3 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.0 |
0.0 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.0 |
0.7 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.0 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.0 |
0.0 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 |
0.0 |
GO:0010662 |
regulation of striated muscle cell apoptotic process(GO:0010662) |
| 0.0 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
